INTRODUCTION

Splenic long-term cultures (LTC) generate nonadherent cells resembling immature myeloid dendritic cells (DC) with a CD11c
ϩ CD11b ϩ DEC-205 -/low 33D1 -F40/80 -CD4 -CD8␣
-DC phenotype; high expression of Fc␥II/IIR, low expression of MHC-II, CD80, and CD40, and high endocytic capacity [1, 2] . LTC-DC are also refractory to LPS, TNF-␣, and CD40L-induced maturation, a key step for DC in initiating T cell responses [3] . While they can endocytose protein antigen and process this for presentation to CD4 ϩ T cells, their capacity to stimulate naive T lymphocytes is limited. Many LTC-DC cannot generate a mixed leukocyte response (MLR) [1, 3] , one of the first discovered functional features of DC [4, 5] . However, all LTC-DC lines tested were capable of stimulating the T H 2 CD4
ϩ cell line D10G4.1 to proliferate and produce lymphokines [1, 2] .
Culture supernatant (CSN) conditioned by LTC-DC has been shown to contain numerous exosome-like vesicles with similar structural properties to vesicles resembling endosomes of cultured cells [6 -9] . These are thought to arise from the fusion of multivesicular endosomes with plasma membrane, resulting in expulsion of vesicles, or exosomes, into the extracellular space. Vesicles from CSN of LTC-DC display endosomal proteins like LAMP-I, but not plasma membrane proteins like CD86, suggesting that they were derived from endosomes late in the endocytic pathway [6] . Differential centrifugation was adopted for vesicle isolation according to published methods for exosome purification for their investigation as modulators of immune responses [7, 8] . Initially, exosome preparations were found to be poor stimulators of lymphocytes in vitro [6] . Here, we report that a few LTC-DC, which produce exosome fractions with potent capacity to stimulate B cell but not T cell proliferation, contain Mycoplasma isolated along with exosomes.
Mycoplasma are the smallest, self-replicating genus of bacteria and contain many potentially mitogenic lipoproteins [10 -12] . Depending on their stage in development, Mycoplasma can vary in form from spherical to filamentous in shape, ranging from 125 nm to 150 m in size [13] , similar to the size distribution of APC-derived exosomes [6 -9] . Mycoplasma have been reported to contaminate up to 80% of surveyed cell lines with limited or no effect on the growth of cultured cells [14] . Cultured DC lines found to be infected with Mycoplasma were therefore used to test the capacity for Mycoplasma to stimulate B cells.
MATERIALS AND METHODS
Animals
Inbred mice were bred in the John Curtin School of Medical Research [Australian National University (ANU), Canberra, ACT, Australia] under specific pathogen-free conditions. B10.A[2R] and C57BL/6J male and female mice aged between 5 and 15 wk were used throughout. C57BL/6J IAa Ϫ/Ϫ and C57BL/6J CD40 Ϫ/Ϫ mice were purchased from the Walter and Elisa Hall Institute (Melbourne, VIC, Australia). Mice were housed and handled according to the guidelines of the ANU Animal and Experimental Ethics Committee.
Cell lines
These included the monkey fibroblast cell line COS-7, the human melanoma cell line MM170, the human B cell line JY, and the murine melanoma cell line B16, kindly provided by H. Warren, J. Abbey, and C. van Broekhoven (ANU). COS-7 was maintained in sDMEM; MM170, JY, and B16 were maintained in RPMI-based medium.
Preparation and treatment of DC
LTC were generated as primary cultures of spleen from inbred mice as described previously [1, 2] . Cells were cultured in supplemented DMEM (Gibco BRL, Grand Island, NY, USA) containing 10% FCS (sDMEM) [3] , and cultured in 5% CO 2 in air at 37°C, with the medium changed as needed. After several weeks, LTC comprised a stromal cell monolayer of fibroblastic and endothelial cells that continuously supported the proliferation and differentiation of hemopoietic cells into nonadherent dendritic-like cells. When required, LTC-DC were harvested at medium change as nonadherent cells released into CSN.
For treatment of cells before experimentation, nonadherent LTC-DC were collected and cultured without stroma in 2 ml sDMEM in the wells of a 24-well tissue culture plate for 24 h at 37°C in 5% CO 2 . Primaquine treatment involved incubation of 10 6 LTC nonadherent cells for 24 h at 37°C with 100 g/ml of drug. Cells were then washed twice in medium before use. Cell viability was assessed by Trypan Blue exclusion. For mitomycin C treatment, 10 6 nonadherent LTC cells were cultured with 50 g/ml mitomycin C for 20 min at 37°C in the dark. Cells were washed three times by resuspension in 10 ml sDMEM followed by centrifugation at 300 g for 5 min. Cells were then cultured for 24 h prior to collection of CSN for exosome preparation.
Vesicle or "exosome" preparation
Differential centrifugation was used to isolate vesicle fractions of CSN based on previously published methods [7, 8] . Cells (5ϫ10 3 -1ϫ10 7 ) were cultured in Յ10 ml sDMEM for 24 h in the absence of stroma to allow the release of vesicles into the CSN. Cells were then depleted by centrifugation at 300 g for 10 min at 4°C. CSN was then centrifuged at 10,000 g for 30 min at 4°C to sediment cell debris. In some cases, cell debris was removed from the CSN by filtration through a 800-nm cellulose cut-off filter (Millipore, Bedford, MA, USA). The vesicle fraction was then isolated by centrifugation of the remaining CSN at 200,000 g for 60 min at 4°C in 26 ml ultracentrifugation bottles (Nalge Company, Rochester, NY, USA) using a Ti70-fixed angle rotor (Beckman Instruments, Porterville, CA, USA). Further fractionation involved passage through 450 nm and 220 nm cut-off filters.
Enzyme treatment of exosomes
Exosome fractions were exposed to protease and DNAase treatment. Exosome fractions from 2.5-7 ϫ 10 5 LTC-DC were incubated with 5 g/ml pronase (protease from S. griseus; Calbiochem-Behring Corp. San Diego, CA, USA) or 2.5 U/75 l DNAase (Amersham, Little Chalfont, Buckinghamshire, UK) for 30 min at 37°C. Exosomes were then diluted to 2.5-7 ϫ 10 4 cell equivalents per milliliter in sDMEM before assessment of their lymphocyte stimulatory capacity. As a control for pronase activity in these assays, CD40L was treated in the same manner and tested for loss of capacity to stimulate lymphocytes in a MLR after pronase treatment.
Antibody staining of cells and flow cytometry
Before staining with specific antibody, cells were incubated for 15 min on ice in 25 l sDMEM/0.1% NaN 3 containing 40 g/ml of Fc block (antibody 2.4G2) specific for Fc␥II/IIIR (CD32/CD16) (Becton Dickinson, Franklin Lakes, NJ, USA). This step was excluded if binding of antibody to Fc␥II/IIIR was being assessed or if second-stage reagents bound cross-reactively to 2.4G2.
For staining cell surface markers, cells were labeled with antibody in a total volume of 50 l sDMEM/0.1% NaN 3 for 30 min on ice. Antibodies were purchased from Becton Dickinson, as affinity purified reagents specific for CD11c (HL3), DEC-205 (NLDC-145), CD86 (GL1), CD3ε (C363-29B), CD4 (GK1.5), CD8 (53-6.7), CD21/CD35 (7G6), CD23 (B3B4), CD69 (H1.2F3), DC (33D1), macrophages (F4/80 and M1/70), B220 (RA3-6B2), Thy1. 2 anti-rat Ig (Serotec) or avidin-PE (Becton Dickinson) in sDMEM/0.1% NaN 3 , followed by three washes in PBS/0.1% NaN 3 . For multicolor staining, the same incubation and washing procedure was repeated for the addition of other specific antibodies and fluorochrome-conjugated secondary reagents as required. Specific binding of antibody was monitored with isotype-matched control antibodies or medium in place of antibody.
For intracellular labeling, cells (2 ϫ 10 5 -10 6 ) were washed three times in PBS, then fixed by resuspension in ice-cold 4% paraformaldehyde/PBS while vortexing, followed by incubation for 5 min at 20°C. After washing in PBS, cells were permeabilized by resuspension in 0.5% Saponin/sDMEM/0.1% NaN 3 for 10 min at 20°C. Cells were then incubated with Fc block for 15 min followed by a 30-min incubation with specific antibody diluted in 0.5% Saponin/sDMEM/0.1% NaN 3 . Cells were then stained as usual except that washes were performed in 0.5% Saponin/sDMEM/0.1% NaN 3 .
Flow cytometry was performed in a FACSort flow cytometer (Becton Dickinson). Cell debris was gated out using a forward scatter threshold of 50, and 10,000-50,000 events were collected. Data analysis was performed using CellQuest software (Becton Dickinson) with postaquisition gating to obtain information on cell subsets. In some experiments, propidium iodide (PI) (2.5 g/ml) was added to cells in PBS prior to flow cytometry for discrimination of dead cells.
CFSE labeling of cells
For assessment of lymphocyte proliferation, cells were stained with 5-(and 6-) carboxyfluorescein diacetate succinimidyl ester [CFSE: Molecular Probes, OR, USA]. Proliferation was detected by successive dilution of stain with each cell division, measured as a decrease in fluorescence by flow cytometry. Cells (Յ10 7 /ml) were resuspended in 1 ml sDMEM and mixed by vortexing with CFSE to give a final concentration of 5 mM. Cells were then incubated at room temperature for 5 min before lysis of red blood cells (RBC) with lysis buffer [0.14 M NH 4 Cl, 0.017 M Tris-base (pH 7.5)], followed by three washes in medium.
Preparation and purification of effector lymphocytes
Spleens or lymph nodes were harvested from mice euthanized by cervical dislocation. Single-cell suspensions were prepared by forcing tissue through a fine wire mesh followed by repeated pipetting in 5 ml sDMEM. Cells were sedimented by centrifugation at 300 g for 5 min for CFSE labeling, followed by RBC lysis. Cell subsets were depleted using antibody-based protocols involving magnetic beads or FACS cell sorting. These procedures involved labeling unwanted cells with rat immunoglobulin [Ig] specific for cell surface markers for 30 min on ice in a volume of 200 l. Cells were then washed three times in ice-cold sDMEM. For depletion by FACS sorting, cells were labeled with FITC conjugated goat IgG anti-rat Ig (Serotec, Oxford, USA] for 30 min at 4°C followed by three washes in 5 ml ice-cold sDMEM. After resuspension in PBS/1% FCS, unstained cells were sorted using a FACStar Plus flow cytometer (Becton Dickinson). This procedure was used for isolating B lymphocytes with Յ1% contaminating cells. Antibodies used for depletion included F4/80, M1/70, 33D1, NLDC-145, 53-6.7, GK1.5, and C363-29B. For magnetic bead depletions, rat Ig-coated cells were incubated with sheep Ig anti-rat Ig Dynabeads (Dynal, Oslo, Norway) for 30 min at 4°C with rotation, using a bead-tocell ratio of 4:1. Bead-coated cells were exposed to a magnet for 2 min, allowing aspiration of target cells. This procedure was routinely used for T cell purification with or without subsets of APC and typically gave Ն90% purity. DC were removed with 33D1 and NLDC-145, macrophages were removed with F4/80 and M1/70, and B cells were removed with RA3-6B2 and TIB120.
MLR and cell stimulation
RBC-depleted spleen cells were cultured in triplicate at 2 ϫ 10 5 cells/well in 96-well plates together with diluting concentrations of stimulators in a total volume of 200 l sDMEM. Stimulators included irradiated (20Gy; 60 Co source) LTC-DC or vesicles prepared from LTC-DC. Control cultures comprised responders or stimulators alone. In some cases, the vesicle fraction of medium was used as a control. As a control, cells were cultured with 10 g/ml LPS (Sigma, St. Louis, MO, USA) or a 1/100 dilution of CD40L (prepared from paraformaldehyde-fixed CD40 ligand baculovirus-infected Sf9 cells and titrated for maximum B cell proliferation, kindly provided by Virginia McPhun, John Curtain School of Medical Research, Canberra, Australia).
DNA synthesis was assessed over the last 16 h of a 3-day culture through the addition of 1 Ci/well of 3 H-thymidine [ 3 H-T] in 20 l sDMEM. Cells were then harvested on to glass-fiber filters, which were then saturated in MicroScint scintillation fluid (Packard, Meridan, CT, USA). Incorporation of label was measured in a Top-Count scintillation counter (Packard). Responses were reported as mean counts per minute (CPM) Ϯ SE of the mean of triplicate samples. Control cultures comprised responders alone or stimulators alone and in some cases the "exosome fraction" of medium was used as a control for particulates sedimented in medium. Background 3 H-T incorporation due to stimulators alone was Ͻ500 CPM. Alternatively, antibody staining and flow cytometry were used at 1 day to identify and gate subsets for analysis of activation by up-regulation of CD69 and CD86, and proliferation was indicated by a decrease in CFSE.
Mycoplasma detection and removal
Cells were harvested, washed, and cultured in fresh medium for 24 h for collection of DNA for PCR analysis of Mycoplasma infection. Since several different Mycoplasma species have been reported to stimulate B cell proliferation in vitro [15] , PCR analysis was performed to assess which species of contaminants were present. DNA from LTC-DC was amplified using Mycoplasma Plus PCR Primer Sets, and fragmented with the restriction enzyme Sau 3A, which generates species-specific fragmentation of Mycoplasma DNA (Stratagene, La Jolla, CA, USA). Mycoplasma species were identified against reference products provided by the manufacturer. DNA was separated in a 1.5% agarose gel containing ethidium bromide. For treatment, cell lines infected with Mycoplasma were cultured for 12 days with enrofloxacin followed by several days recovery prior to use in experiments [16] .
RESULTS
Lymphocyte proliferation induced by exosome fractions of LTC-DC
Some LTC-DC were found to produce exosome fractions with potent capacity for generating a dose-dependent mitotic response in both allogeneic and syngeneic spleen cells that was equivalent to that generated by the LTC-DC from which they were derived ( Fig. 1A and data not shown). This activity was not observed in the vesicle fraction of culture medium (data not shown). Lymphocyte stimulation induced by the vesicle fraction was first detectable after 2 h of culture and increased to peak levels by 24 h (Fig. 1B) . When CSN was passed through filters of reducing pore size, including 800 nm, 450 nm, and 220 nm, the 800-nm filtrate contained the full mitogenic activity of both unfractionated CSN and the vesicle fraction isolated by differential centrifugation (Fig. 1C) . Large particulates, such as cell debris removed by 800-nm filtration, were therefore not responsible for lymphocyte stimulation. Passage of CSN through a 450-nm cut-off filter significantly reduced stimulatory capacity, and stimulatory factors were further depleted, although not completely after passage through a 220-nm cut-off filter (Fig. 1C) . These results support the particulate nature of the lymphostimulatory factors secreted by LTC-DC and suggested a heterogeneous mix of particles of size range 200 to 800 nm consistent with exosomes [6] .
Specific proliferation of B cells and not T cells
DC-derived exosomes have been reported to stimulate T cell responses, via bystander APC [17, 18] . Therefore, to determine the necessity for bystander APC in our model, T cell preparations containing either DC, macrophages, or B cells were compared with unfractionated spleen cells for capacity to respond to stimulatory LTC-DC-derived exosome fractions. LTC-DC and their vesicles stimulated lymphocyte proliferation only in the presence of B cells ( Fig. 2A) . Exosomes could require B cells to stimulate T cells or could stimulate B cells in their own right. In fact, semipurified B cells, but not B cell-depleted spleen cells were then shown to proliferate in response to LTC-DC and their vesicles (Fig. 2B) . Antibody staining and flow cytometry of spleen cells stimulated with LTC-DC or their exosome fraction revealed increased numbers of B220
ϩ B cells and decreased CD3ε ϩ T cells after 3 days of culture (data not shown). CFSE analysis of the responding cell subset confirmed that B cells and not T cells were responding (data not shown).
Exosome fractions stimulate B cells independently of T cells
The requirement for T cell help in B cell responses induced by DC is well documented. The importance of CD4 ϩ T cells in the B cell response induced by LTC-DC or their vesicle fraction was therefore tested by stimulating spleen cells from mice that lack normal expression of MHC-II and have very reduced numbers of CD4 ϩ T cells (Fig. 3A) . LTC-DC and their vesicle fraction efficiently activated MHC-II-deficient B cells in the absence of CD4 ϩ T cells inducing 50-65% of B cells from both normal and MHC-II-deficient mice to up-regulate CD69 and CD86 after 24 h of coculture, and 74-82% of B cells to undergo blastogenesis and divide after 3 days of culture (Fig. 3B) . This response resembled the T cell-independent LPS response. LPS contamination, however, was shown not to be responsible for exosomemediated B cell responses since the LPS inhibitor, polymyxin B, had no effect on the capacity of LTC-DC-derived vesicles to stimulate lymphocytes, but severely inhibited the ability of peak mitogenic doses of LPS to induce lymphocyte proliferation (Fig. 4A) . Furthermore, CD40L, a known B cell mitogen, was also excluded since LTC-DC-derived vesicle fractions stimulated B cell proliferation equally in C57BL/6J CD40 Ϫ/Ϫ and C57BL/6J mice (Fig. 4B ).
Specific inhibitors of B cell proliferation
To directly test whether the lymphostimulatory activity for B cells was due to secreted particles, the trafficking inhibitor primaquine was used to block the secretory pathway at the trans-Golgi network. This drug also prevents vesicles recycling from endocytic compartments to the plasma membrane, including transport of molecules from MHC-II-rich compartments (MIIC) to the plasma membrane in DC [19 -21] . It could thus be a potential inhibitor of exosome release, which is thought to occur upon MIIC fusion with the plasma membrane. Primaquine completely inhibited the capacity of LTC-DC-derived vesicles to stimulate lymphocytes ( Fig. 5A ) without affecting cell viability (data not shown). Mitomycin C, reported to be an inhibitor of B cell stimulation by exosomes in CSN from mast cells [9, 22] , was also found to completely inhibit the lymphostimulatory capacity of LTC-DC and their derived vesicles (Fig. 5B) . Furthermore, DNase treatment of vesicles excluded a role for nucleic acid like CpG motifs (Fig. 5C ). Pronase had no effect on the stimulatory capacity of the exosome fraction, despite strongly inhibiting the B cell mitogenic effect of CD40L (Fig. 5D ). These data suggested a potential role for lipids in the B cell mitogenic response.
Identification of a cellular pathogen as the lymphoproliferative agent
A role for Mycoplasma-derived lipids was considered initially since they are frequent contaminants of cultured cells and have mitogenic activity for leukocytes [10 -12] . PCR assays confirmed that a few LTC-DC maintained for over a year were infected with Mycoplasma and that Mycoplasma components were also present in LTC-DC-derived vesicle preparations. Both M. arginini and M. orale were detected in different cultures by PCR analysis (data not shown). Both have been reported to stimulate B cell proliferation [15] . LTC-DC-derived vesicles containing different Mycoplasma species were also shown to stimulate blastogenesis in B220 ϩ but not CD4 ϩ or CD8 ϩ lymphocytes (data not shown). To investigate further the role of Mycoplasma in B cell proliferation, infected LTC were treated with Mycoplasma removal agent (enrofloxocin) and confirmed clear by PCR analysis. Treated LTC-DC and their vesicle fraction completely lost capacity to stimulate mitosis of lymphocytes (Fig. 6, A and B) . Furthermore, some Mycoplasma-free LTC-DC, never exposed to Mycoplasma removal agent, were incapable of generating lymphocyte responses (data not shown). Recurrence of infection in one culture also correlated with capacity to stimulate B lymphocyte responses (data not shown). Responses were due to B220 ϩ lymphocytes, and not Thy1.2 ϩ lymphocytes, as confirmed by antibody staining and gating of cell subsets using flow cytometry (Fig. 6C) .
Mycoplasma stimulate B cells independently of DC
In line with other studies, Mycoplasma contaminants could not be cultured independently of LTC-DC using either liquid or solid medium, possibly a reflection of the scarcity of genes in Mycoplasma that are normally involved in major biochemical pathways [15] . Therefore, further experiments tested whether Mycoplasma, in the vesicle fraction of LTC-DC stimulated B cells independently of antigen presenting DC by assessing whether Mycoplasma produced by DC could transfer their B cell stimulation capacity upon infection of other cells. Several cell lines received from outside laboratories, including the monkey fibroblast cell line COS-7, the human melanoma cell line MM170, the human B cell line JY, and the murine melanoma cell line B16, were screened by PCR for Mycoplasma infection using primers specific for conserved gene sequences of 16S rRNA within the Mycoplasma genus [23] . This analysis showed that CSN from all cell lines tested except B16 contained Mycoplasma (Fig. 7A) . CSN collected after a 24 h culture of washed cells from infected cell lines generated 5 . The effect of primaquine, mitomycin C, DNAase, and pronase treatment on the capacity of LTC-DC-derived exosome-like vesicles to stimulate lymphocytes. The ability of drugs and degradative enzymes to inhibit production of the stimulatory exosome fraction from LTC-DC was assessed in a MLR. For primaquine and mitomycin C treatment, exosome fractions were prepared from treated and untreated LTC-DC and compared (along with LTC-DC, where appropriate). For pronase and DNAase treatment, exosome fractions were treated directly for 30 min at 37°C prior to dilution in medium. Values are the capacity of LTC-DC or the exosome fractions to induce 3 H-T incorporation in C57BL/6J-derived lymphocytes relative to medium alone as a control. Data represent mean CPMϮSE (nϭ3). (A) Exosome fractions (Exo) were derived from untreated LTC-DC and LTC-DC treated with 100 g/ml primaquine (PQN) for 24 h. (B) LTC-DC were treated with or without mitomycin C (Mito C) (50g/ml) for 20 min at 37°C, and then were washed and cultured without stroma for 24 h to accumulate exosomes. (C) Stimulatory capacity of Exo untreated and treated (ExoϩDNAase) with DNAase (2.5 U/75 l). (C) Stimulatory capacity of Exo untreated and treated (Exoϩpronase) with pronase (5 g/ml). As a positive control for pronase activity, CD40L was treated in the same manner and tested for stimulatory capacity.
lymphocyte proliferative responses comparable to that generated by optimal concentrations of CD40L (Fig. 7B) . Both whole cells and cell depleted-CSN from infected cell lines activated splenic B cells but not T cells to up-regulate CD69 after an 18-h culture, similar to responses induced by CD40L (Fig. 7C) . Neither B16 cells nor B16 CSN activated any lymphocyte response (Fig. 7C) .
The Mycoplasma infection status of cell lines was found to correlate with their capacity to stimulate B lymphocytes. Following treatment with enrofloxacin, COS-7, MM170, and JY were cleared of Mycoplasma, resulting in loss of B cell stimulatory capacity (Fig. 8B-D) . Mycoplasma contaminated LTC-DC could also transfer B cell stimulatory capacity to uninfected B16 cells following exposure to CSN from infected cells (Fig. 8A) . Taken together, these data strongly suggest that Mycoplasma can stimulate B cell proliferation, independently of DC-derived factors or exosomes. The possibility that Mycoplasma-infected cells also contribute to B cell stimulation cannot be ruled out. However this would have to be a phenomenon common to many different cell types.
Characteristics of the B cell response to Mycoplasma
B cell activation for Ig production
The opportunity existed to investigate more specifically the B cell response due to Mycoplasma. Infected LTC-DC and their "Mycoplasma fraction" were compared with LPS for capacity to stimulate proliferation of subsets of B cells. A comparison of peak responses of viable CFSE-labeled B cells after 3 days of culture showed that LTC-DC and their Mycoplasma fraction induced a similar number of B220 ϩ PI -B cells to undergo blasting and cell division with 74-82% of B cells responding above background (Fig. 9A) . In comparison with LPS, the Mycoplasma fraction gave less cells undergoing 4-6 divisions (Fig. 9A) . Further experiments tested whether the Mycoplasma fraction isolated from LTC-DC could initiate B cell differentiation into plasma cells with isotype switching. Spleen cells were stimulated with infected LTC-DC, their Mycoplasma fraction, LPS, and medium as a control, and the presence of soluble Ig was detected in CSN using an ELISA assay. Both infected LTC-DC and their Mycoplasma fraction induced Ig secretion by 3 days of culture, peaking at 6 days at levels comparable with that induced by 5 g/ml of LPS (data not shown). Ig levels dropped after 12 days, although levels continued to increase in cultures with added LPS (data not shown). Spleen cells stimulated with infected LTC-DC or their Mycoplasma fraction were also examined for both surface and intracellular expression of different Ig isotypes over time. LPS induced Ig class switching in CFSE-labeled B cells from IgM to IgG 3 by four cell divisions (Fig. 9B) [24] . However, neither infected LTC-DC nor their Mycoplasma fraction induced detectable surface or intracellular expression of Ig isotypes other than IgM (Fig. 9C) even after 5 or 6 divisions of B cells (all data not shown).
Polyclonal activation of all B cell subsets
The LTC-DC-derived Mycoplasma fraction induces a polyclonal B cell response despite the use of specific pathogen-free animals. It is not clear whether B cell responses involved only naive B cells. To assess this, cells were gated on the basis of size (forward scatter) and expression of IgD to identify small, resting naive B cells. These were then assessed for activation after culture with Mycoplasma-containing fractions by up-regulation of CD69 expression. After 0.5 days, culture of spleen cells with either infected LTC-DC, their Mycoplasma fraction, or LPS, both large and small IgD ϩ B cells increased surface expression of CD69, although larger cells gave better responses (Fig. 10) . IgD ϩ B cells also underwent several rounds of division by 4 days of culture with infected LTC-DC and their Mycoplasma fraction (data not shown). Like LPS, infected LTC-DC and their Mycoplasma fraction stimulated both large B cells and small, resting naive B cell populations, consistent with polyclonal activation. Mature B cells comprise two distinct types, marginal zone (MZ) B cells, which are CD23 low and CD21 high, and follicular (FO) B cells, which are CD23 high and CD21 intermediate [25] . These are thought to respond differently upon activation, with MZ B cells inducing a more rapid blast response than FO B cells after LPS treatment [25] . Precursor B cells also exist in spleen. These are divided into the transitional B cell subsets, T1 and T2, representing stages in selection of the mature B cell repertoire [26] . Like MZ B cells, transitional B cells express high levels of IgM not expressed on FO B cells. T1 B cells can be further discriminated from T2 B cells by low or undetectable levels of CD23, as for MZ B cells. T1 can be distinguished from MZ B cells by the absence of CD21 [26] . Spleen cells were cultured for 3 days with the Mycoplasma fraction of LTC-DC and divided into T1, T2, MZ, and FO B cells on the basis of CD21, CD23, and IgM marker expression. The response of splenic B cell subsets to the vesicle fraction of infected LTC-DC was then compared with LPS as a control mitogen.
Both LTC-DC-derived vesicles and LPS were mitogenic for all B cell subsets. Overall, 0.4-2.1% of lymphocytes displayed T1 markers, 16-19% displayed T2 markers, 4.8-11% displayed MZ markers and 41-50% displayed FO B cell markers after 3 days of culture under all conditions of stimulation (Fig. 11A) . However, there was an approximate 2-to 5-fold increase in population size after stimulation with the Mycoplasma containing fraction or LPS, indicated by a specific increase in the total cell number within each B cell subset (Fig. 11B) . The majority [57-90%] of B cells in each subpopulation responding to vesicles or LPS were blasts. There was no specific induction of blastogenesis within a particular B cell subset after stimulation with vesicles, as opposed to LPS.
DISCUSSION
This study shows that Mycoplasma contaminants in LTC-DC and their exosome preparations are responsible for inducing B cell mitogenesis either directly or in conjunction with cell factors. Mycoplasma isolated as a vesicle fraction of infected cells can stimulate B cell responses independently of LTC-DC, and the responsible components are resistant to proteases and DNases, suggesting a role for lipoproteins probably Mycoplasma-derived. This response was inhibited by mitomycin C [9, 22] and primaquine, an inhibitor of membrane transport. Nonviable contaminants were excluded as causative since the production of stimulatory particles correlated with in vitro culture of LTC-DC. Furthermore, polymyxin B inhibition assays preclude a role for the lipid A component of LPS. These results have implications for our understanding of Mycoplasma-induced immunomodulation and on how the study of exosomes and cellular immune responses can be affected by microbial contaminants.
Previous studies have shown that LTC-DC, but not their exosome fraction, can initiate an MHC-II-restricted response in TCR-Tg CD4 ϩ T cells [3] . This confirms that LTC-DC can generate T cell responses independently of Mycoplasma infection. These findings may also explain results demonstrating that mitomycin C has an inhibitory effect on the ability of LTC-DC and their exosome fraction to induce an MLR but has no effect on the capacity of LTC-DC to stimulate the T cell clone, D10.G4.1 [27] . Mitomycin C is known to crosslink DNA with absolute specificity for the sequence CpG [28] . Because of the abundance of CpG in prokaryote cells, mitomycin C is a potent antibiotic and a potent Mycoplasma-inhibiting drug [29] . Whether Mycoplasma infection has other effects on LTC-DC is not clear. Mycoplasma can induce human monocyte-derived DC to undergo maturation and to secrete cytokines, like IL-6 and IL-12 [30] . Preliminary investigations, however, indicate that the partially mature properties displayed by LTC-DC are not altered by Mycoplasma infection. These include expression levels of immunomodulatory molecules, like MHC-II and CD86, endocytotic capability, inability to stimulate a normal repertoire of naive T cells, and refractoriness to LPS activation (data not shown).
The size of the B cell stimulatory agent in LTC-DC CSN compares with the size of exosome-like vesicles observed previously in CSN [6] . Mycoplasma also fit this size distribution [13] . Published reports showing whole mount electron micrographs of Mycoplasma demonstrate them to be highly pleomorphic in structure [31] . They do not resemble the uniform spherical structures observed by whole mount electron microscopy of exosome fractions derived from LTC-DC [6] . Furthermore, antibody staining of exosome fractions has indicated expression of LAMP-1, a protein reported to be expressed by APC-derived exosomes [7] , and also expressed intracellularly by LTC-DC. The finding of Mycoplasma as a contaminant of some LTC does not detract from the finding that LTC-DC do, in fact, produce exosome-like vesicles. Overall, it appears that exosome isolation procedures can also result in coisolation of Mycoplasma. To date, Mycoplasma have not been observed under electron microscopy of either cells or vesicle fractions. Mycoplasma express cytadherence and accessory proteins, which allow adherence to host cell surfaces [32] . Other studies have also reported Mycoplasma within cells, or capable of fusing their outer membrane with the plasma membrane of host cells, resulting in cell fusion [32] . These findings have important implications for studies on exosomes. Previous studies ruled out the possibility that exosomes were derived from plasma membrane components or apoptotic bodies [6 -8, 33] . However, there has been no investigation of exosome fractions for Mycoplasma or other microorganisms. It is important to note that much of the work done on leukocyte-derived vesicles, including functional studies, has involved cell lines, like the B cell lines JY and RN [7] , the DC line D1 [8, 17] , and the mast cell lines P815 and MC/9 [9, 34] . Because of the ease with which Mycoplasma infection can occur in in vitro cultured cell lines [14] and the difficulty of isolating exosomes away from Mycoplasma, it will be important to assess the impact of these results on the broader field of exosome biology. Size restriction filters and sucrose gradients are current methods used to fractionate vesicles from other cellular components or cell debris [17, 35] . These cannot be guaranteed to isolate vesicles free of Mycoplasma contaminants.
Previous studies have identified exosomes to be mediators of both T and B lymphocyte activation, cytokine production by leukocytes, and DC maturation [8, 9, 34] . These are also known functions of Mycoplasma [15] . However, most studies have failed to directly relate the lymphocyte modulation induced by the exosome fraction with vesicles present in this fraction. For instance, CSN factors derived from mast cells can replace cells in generating nonspecific responses in T cells and also resting B cells, leading to blastogenesis, mitosis, and IgM secretion [22] . This response has been attributed to exosome-like vesicles present in the CSN of mast cells [9] . Vesicles are also thought to be responsible for the capacity of CSN factors from ϩ responder cells after 4 days of culture were assessed for Ig isotype expression by surface and intracellular labeling using antibody staining and flow cytometry on fixed, permeabilized cells. mast cells to induce maturation of DC in vitro and to have adjuvant effects on cytokine secretion in vivo similar to LPS [34] . The mast cell-derived agent was isolated by differential centrifugation of mast cell CSN, from which exosome-like vesicles could also be isolated [9] . However, Mycoplasma contaminants can also be isolated using these procedures. Importantly, mast cell-derived factors mediating the responses observed were found to be protease-resistant but extremely sensitive to mitomycin C treatment [22] . These properties resemble those of the Mycoplasma-contaminated exosome fraction derived from LTC-DC.
Most work characterizing B cell responses induced by Mycoplasma-infected cells or their isolated vesicle fraction were performed using cells derived from one LTC culture, B6BQ. Cells were contaminated by M. arginini, which can act as a T cell-independent polyclonal B cell mitogen, resulting in growth and Ig secretion of resting B cells with no effect on T cells [12, 36] . This study extends those findings and shows that polyclonal T cell-independent B cell responses induced by M. arginini are triggered through a lipid A (polymyxin B)-independent mechanism that is DNAase-and pronase-resistant but sensitive to mitomycin C and primaquine treatment. B cell mitogenic effects of Mycoplasma appear to be due to lipoproteins. Mycoplasma express high levels of lipoproteins in diverse compositions anchored to the outer leaflet of their plasma membrane bilayer [10] . All membrane-anchored lipoproteins contain a lipolated amino-terminal cysteine residue [10] , with immunomodulatory activity independent of attached protein [37, 38] . M. fermentans contains lipid-associated membrane proteins that are potent inducers of murine T cellindependent B cell proliferation and Ig secretion without induction of isotype switching [11] . Studies have identified a lipopeptide, MALP-2, in M. fermentans, with similar properties to the endotoxin LPS but acting through a pathway independent of Toll-like receptor (TLR)-4, which is required for LPS signaling [39, 40] . MALP-2 is identical to the N-terminal lipid moiety present on two other M. fermentans immunogenic lipoproteins, M161Ag and P48 [37] . MALP-2 and M161Ag signal through TLR-2, which binds the N-terminal lipid moiety of a number of different lipoproteins [37, 39] .
The finding that Mycoplasma-infected cells or vesicles produced by those cells can stimulate polyclonal activation of all B cell subsets in spleen, including the T1 and T2 transitional populations of B cells, could have important implications for autoimmune sequelae associated with Mycoplasma infection [41, 42] . Immature B cells from bone marrow develop into transitional T1 B cells, which migrate selectively to the spleen [26] . Here, they differentiate into all major B cell populations, including T2 transitional B cells, mature IgD ϩ FO B cells, and mature MZ B cells. Transitional B cells are highly sensitive to negative selection dependent on B cell receptor interaction with antigen in a process that has not yet been fully charac- terized [26, 43, 44] . If Mycoplasma can promote the outgrowth of T1 and T2 transitional B cells, then it could induce proliferation of potentially autoreactive B cells. Mycoplasma pneumoniae in humans and Mycoplasma pulmonis in mice are frequently described in association with production of polyclonal IgM autoreactive to red blood cells and autoimmune hemolytic anemia [41, 42] . This finding may provide insight into a potential mechanism involved in Mycoplasma-induced autoimmune disease.
The strong inhibitory effect of primaquine on Mycoplasma, with no concomitant effect on the viability of host LTC-DC, indicates that it may be an effective treatment for Mycoplasmainduced disease. Primaquine is already used for treatment of Pneumocystis and Plasmodium infections in humans [45, 46] , and Mycoplasma have increasing importance, as a number of diseases implicate Mycoplasma as a causative agent, including pneumonia [47] . Increased resistance to macrolide drugs, often used to treat Mycoplasma respiratory diseases, makes the search for new drugs very important [48] .
This study has characterized B lymphocytes responding to Mycoplasma-infected cells, and particularly to cells infected with M. arginini. Although the B cell responses generated by M. arginini-infected cells are similar to those induced by the most recognized bacterial modulin, LPS, they are qualitatively different acting through moieties independent of lipid A. This study emphasizes the potential of Mycoplasma-infected cells for generating T cell-independent polyclonal outgrowth of all major B cell subsets in spleen. 
